The Triumph Of Thorazine And Prozac

April 2004
Health & Stress;2004, Issue 4, p3
Focuses on the success of Thorazine and Prozac in treating schizophrenia. Side effects of Thorazine; Development of tardive dyskinesia.


Related Articles

  • Pharmacogenomics as an Adjunct in Death Certification of Amitriptyline, Nortriptyline Clomipramine, and Fluoxetine.  // Journal of Analytical Toxicology;May/Jun2004, Vol. 28 Issue 4, p278 

    Presents the abstract of the study "Pharmacogenomics as an Adjunct in Death Certification of Amitriptyline, Nortriptyline Clomipramine, and Fluoxetine," by Jimmy Crockett.

  • Case History: The Discovery of Fluoxetine Hydrochloride (Prozac). Wong, David T.; Perry, Kenneth W.; Bymaster, Frank P. // Nature Reviews Drug Discovery;Sep2005, Vol. 4 Issue 9, p764 

    In the early 1970s, evidence of the role of serotonin (5-hydroxytryptamine or 5-HT) in depression began to emerge and the hypothesis that enhancing 5-HT neurotransmission would be a viable mechanism to mediate antidepressant response was put forward. On the basis of this hypothesis, efforts to...

  • Death Following Long-Term Fluoxetine Use.  // Journal of Analytical Toxicology;May/Jun2004, Vol. 28 Issue 4, p300 

    Presents the abstract of the study "Death Following Long-Term Fluoxetine Use," by Dora Schranz and colleagues.

  • A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Young, J. P. R.; Coleman, A.; Lader, M. H.; Young, J P // British Journal of Psychiatry;Sep87, Vol. 151, p337 

    Fluoxetine, a selective serotonin uptake inhibitor (mean dose 73 mg each morning) was compared with amitriptyline (mean dose 122 mg at night) in a double-blind study of 64 depressed out-patients. Fifty patients completed the 6-week trial. The drugs did not differ with respect to psychiatrists'...

  • Case of Fluoxetine-Induced Remission of Raynaud's Phenomenon--A Case Report. Bolte, Mary Ann; Avery, David // Angiology;Feb1993, Vol. 44 Issue 2, p161 

    The authors report complete remission of digital ischemia, blanching, ulceration, pain, and poor fingernail growth associated with Raynaud's phenomenon in a thirty-one-year-old, nondepressed woman treated with fluoxetine.

  • Fluoxetine dose and outcome in antidepressant drug trials. Barbui, Corrado; Hotopf, Matthew; Garattini, Silvio // European Journal of Clinical Pharmacology;Sep2002, Vol. 58 Issue 6, p379 

    Objective. One potential for bias in the evaluation of a new drug is the dose used, both for the new compound and for the reference drug. The present study compared fluoxetine dose and outcome in trials in which fluoxetine was the experimental drug with trials in which it was the comparator....

  • Prozac. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p634 

    An encyclopedia entry for "Prozac" is presented. It refers to a brand name for the antidepressant drug fluoxetine.

  • Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. Versiani, Marcio; Moreno, Ricardo; Ramakers-van Moorsel, Catharina J.A.; Schutte, Albert J.; Comparative Efficacy Antidepressants Study Group // CNS Drugs;2005, Vol. 19 Issue 2, p137 

    Introduction: Depression is a major global problem associated with large medical, sociological and economic burdens. Mirtazapine (Remeron®, Organon NV, The Netherlands) is an antidepressant with a unique mechanism of action that has similar or superior efficacy to TCAs and SSRIs in...

  • Prozac saves?  // New Scientist;6/17/2006, Vol. 190 Issue 2556, p36 

    The article focuses on a study conducted by Michael Milane and colleagues at the University of California, Los Angeles which revealed that Prozac is not linked to an increased risk of suicide. It was observed that increase in the number of prescriptions for Prozac resulted in decline in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics